Skip to main content

Advertisement

Log in

Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis

  • CASE REPORT
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

We report a case of reversible sensineural hearing loss due to hydroxychloroquine (HQ) treatment. The patient was a 34-year-old woman with 1 year of rheumatoid arthritis (RA). She developed reversible hearing loss after 5 months of HQ treatment. Sensineural deafness has previously been reported with chloroquine treatment, but this is the first report of ototoxicity associated with HQ in RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 6 March 2000 / Accepted 9 May 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seçkin, Ü., Özoran, K., Ikinciogullari, A. et al. Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatology International 19, 203–204 (2000). https://doi.org/10.1007/s002960000054

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002960000054

Navigation